Temozolomide/Vaccination Combo May Work as Glioblastoma Therapy

CHICAGO — Temozolomide may not be incompatible with immunologic approaches for the treatment of glioblastoma, based on data from a small analysis presented at the annual meeting of the American Society of Clinical Oncology.